vs
Ecovyst Inc.（ECVT）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是Ecovyst Inc.的1.6倍（$321.1M vs $199.4M），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 34.0%），Ecovyst Inc.自由现金流更多（$22.9M vs $-133.8M）
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
ECVT vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.6倍
$199.4M
营收增速更快
MDGL
高出176.8%
34.0%
自由现金流更多
ECVT
多$156.8M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.4M | $321.1M |
| 净利润 | — | $-58.6M |
| 毛利率 | 23.4% | — |
| 营业利润率 | 10.9% | -18.6% |
| 净利率 | — | -18.2% |
| 营收同比 | 34.0% | 210.8% |
| 净利润同比 | — | 1.4% |
| 每股收益（稀释后） | $0.06 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECVTMDGL
| Q4 25 | $199.4M | $321.1M | ||
| Q3 25 | $204.9M | $287.3M | ||
| Q2 25 | $176.1M | $212.8M | ||
| Q1 25 | $143.1M | $137.3M | ||
| Q4 24 | $148.9M | $103.3M | ||
| Q3 24 | $153.9M | $62.2M | ||
| Q2 24 | $154.0M | — | ||
| Q1 24 | $141.6M | $0 |
净利润ECVTMDGL
| Q4 25 | — | $-58.6M | ||
| Q3 25 | $-79.3M | $-114.2M | ||
| Q2 25 | $6.0M | $-42.3M | ||
| Q1 25 | $-3.6M | $-73.2M | ||
| Q4 24 | — | $-59.4M | ||
| Q3 24 | $14.3M | $-107.0M | ||
| Q2 24 | $8.3M | — | ||
| Q1 24 | $1.2M | $-147.5M |
毛利率ECVTMDGL
| Q4 25 | 23.4% | — | ||
| Q3 25 | 25.4% | — | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 13.3% | 96.7% | ||
| Q4 24 | 28.9% | — | ||
| Q3 24 | 29.3% | — | ||
| Q2 24 | 27.3% | — | ||
| Q1 24 | 23.5% | — |
营业利润率ECVTMDGL
| Q4 25 | 10.9% | -18.6% | ||
| Q3 25 | 13.8% | -39.7% | ||
| Q2 25 | 9.0% | -22.2% | ||
| Q1 25 | -0.7% | -57.8% | ||
| Q4 24 | 15.1% | -64.8% | ||
| Q3 24 | 17.9% | -187.1% | ||
| Q2 24 | 14.1% | — | ||
| Q1 24 | 9.5% | — |
净利率ECVTMDGL
| Q4 25 | — | -18.2% | ||
| Q3 25 | -38.7% | -39.8% | ||
| Q2 25 | 3.4% | -19.9% | ||
| Q1 25 | -2.5% | -53.4% | ||
| Q4 24 | — | -57.5% | ||
| Q3 24 | 9.3% | -172.0% | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 0.9% | — |
每股收益（稀释后）ECVTMDGL
| Q4 25 | $0.06 | $-2.55 | ||
| Q3 25 | $-0.69 | $-5.08 | ||
| Q2 25 | $0.05 | $-1.90 | ||
| Q1 25 | $-0.03 | $-3.32 | ||
| Q4 24 | $-0.26 | $-2.50 | ||
| Q3 24 | $0.12 | $-4.92 | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.01 | $-7.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.2M | $198.7M |
| 总债务越低越好 | $392.6M | $339.9M |
| 股东权益账面价值 | $603.4M | $602.7M |
| 总资产 | $1.3B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.65× | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资ECVTMDGL
| Q4 25 | $197.2M | $198.7M | ||
| Q3 25 | $82.0M | $295.7M | ||
| Q2 25 | $69.6M | $186.2M | ||
| Q1 25 | $127.5M | $183.6M | ||
| Q4 24 | $131.4M | $100.0M | ||
| Q3 24 | $123.5M | $232.7M | ||
| Q2 24 | $83.3M | — | ||
| Q1 24 | $103.1M | $622.5M |
总债务ECVTMDGL
| Q4 25 | $392.6M | $339.9M | ||
| Q3 25 | $854.8M | $339.8M | ||
| Q2 25 | $856.6M | $118.4M | ||
| Q1 25 | $859.0M | $118.0M | ||
| Q4 24 | $860.8M | $117.6M | ||
| Q3 24 | $862.7M | $117.1M | ||
| Q2 24 | $862.4M | — | ||
| Q1 24 | $866.2M | $116.1M |
股东权益ECVTMDGL
| Q4 25 | $603.4M | $602.7M | ||
| Q3 25 | $607.9M | $625.7M | ||
| Q2 25 | $692.4M | $696.0M | ||
| Q1 25 | $698.7M | $710.6M | ||
| Q4 24 | $700.5M | $754.4M | ||
| Q3 24 | $729.4M | $777.2M | ||
| Q2 24 | $717.3M | — | ||
| Q1 24 | $711.4M | $850.8M |
总资产ECVTMDGL
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.8B | $1.0B | ||
| Q1 25 | $1.8B | $996.6M | ||
| Q4 24 | $1.8B | $1.0B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.8B | $1.1B |
负债/权益比ECVTMDGL
| Q4 25 | 0.65× | 0.56× | ||
| Q3 25 | 1.41× | 0.54× | ||
| Q2 25 | 1.24× | 0.17× | ||
| Q1 25 | 1.23× | 0.17× | ||
| Q4 24 | 1.23× | 0.16× | ||
| Q3 24 | 1.18× | 0.15× | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.22× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.8M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | $22.9M | $-133.8M |
| 自由现金流率自由现金流/营收 | 11.5% | -41.7% |
| 资本支出强度资本支出/营收 | 9.4% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $69.9M | — |
8季度趋势，按日历期对齐
经营现金流ECVTMDGL
| Q4 25 | $41.8M | $-133.5M | ||
| Q3 25 | $55.3M | $79.8M | ||
| Q2 25 | $33.0M | $-47.1M | ||
| Q1 25 | $10.3M | $-88.9M | ||
| Q4 24 | $43.5M | $-104.5M | ||
| Q3 24 | $59.9M | $-67.0M | ||
| Q2 24 | $10.0M | — | ||
| Q1 24 | $36.5M | $-149.2M |
自由现金流ECVTMDGL
| Q4 25 | $22.9M | $-133.8M | ||
| Q3 25 | $53.2M | $79.0M | ||
| Q2 25 | $7.8M | — | ||
| Q1 25 | $-14.0M | — | ||
| Q4 24 | $30.9M | $-104.7M | ||
| Q3 24 | $53.6M | $-67.8M | ||
| Q2 24 | $-9.3M | — | ||
| Q1 24 | $19.1M | $-149.5M |
自由现金流率ECVTMDGL
| Q4 25 | 11.5% | -41.7% | ||
| Q3 25 | 26.0% | 27.5% | ||
| Q2 25 | 4.4% | — | ||
| Q1 25 | -9.8% | — | ||
| Q4 24 | 20.7% | -101.3% | ||
| Q3 24 | 34.9% | -109.0% | ||
| Q2 24 | -6.1% | — | ||
| Q1 24 | 13.5% | — |
资本支出强度ECVTMDGL
| Q4 25 | 9.4% | 0.1% | ||
| Q3 25 | 1.0% | 0.3% | ||
| Q2 25 | 14.4% | 0.0% | ||
| Q1 25 | 16.9% | 0.0% | ||
| Q4 24 | 8.5% | 0.2% | ||
| Q3 24 | 4.1% | 1.3% | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 12.3% | — |
现金转化率ECVTMDGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.52× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.21× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 29.90× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
